BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35197005)

  • 1. Risk stratification for predicting postoperative recurrence/metastasis of colorectal cancer by grade of venous invasion coupled with histological subtype.
    Imai Y; Ichinose M
    BMC Gastroenterol; 2022 Feb; 22(1):79. PubMed ID: 35197005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma.
    Imai Y; Yamagishi H; Fukuda K; Ono Y; Inoue T; Ueda Y
    World J Gastroenterol; 2013 Jul; 19(25):3957-68. PubMed ID: 23840140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective clinicopathologic study of venous invasion in colorectal cancer.
    Shirouzu K; Isomoto H; Kakegawa T; Morimatsu M
    Am J Surg; 1991 Sep; 162(3):216-22. PubMed ID: 1928581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Objective criteria for the grading of venous invasion in colorectal cancer.
    Sato T; Ueno H; Mochizuki H; Shinto E; Hashiguchi Y; Kajiwara Y; Shimazaki H; Hase K
    Am J Surg Pathol; 2010 Apr; 34(4):454-62. PubMed ID: 20216202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical utility of the combination of T stage and venous invasion to predict survival in patients undergoing surgery for colorectal cancer.
    Roxburgh CS; McMillan DC; Richards CH; Atwan M; Anderson JH; Harvey T; Horgan PG; Foulis AK
    Ann Surg; 2014 Jun; 259(6):1156-65. PubMed ID: 24100338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of venous invasion by Elastica van Gieson stain and tumor budding predicts local and distant metastases in patients with T1 stage colorectal cancer.
    Suzuki A; Togashi K; Nokubi M; Koinuma K; Miyakura Y; Horie H; Lefor AT; Yasuda Y
    Am J Surg Pathol; 2009 Nov; 33(11):1601-7. PubMed ID: 19574884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Signatures of Mucinous and Poorly Differentiated Subtypes of Colorectal Adenocarcinomas by a Propensity Score Analysis of an Independent Patient Database from Three Phase III Trials.
    Kanda M; Oba K; Aoyama T; Kashiwabara K; Mayanagi S; Maeda H; Honda M; Hamada C; Sadahiro S; Sakamoto J; Saji S; Yoshikawa T;
    Dis Colon Rectum; 2018 Apr; 61(4):461-471. PubMed ID: 29521828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.
    Yamagishi H; Imai Y; Okamura T; Fukuda K; Ono Y; Ban S; Inoue T; Ueda Y
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1815-22. PubMed ID: 23808938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of venous invasion in stage IB node-negative gastric cancer.
    Araki I; Hosoda K; Yamashita K; Katada N; Sakuramoto S; Moriya H; Mieno H; Ema A; Kikuchi S; Mikami T; Watanabe M
    Gastric Cancer; 2015 Apr; 18(2):297-305. PubMed ID: 24687437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucinous Adenocarcinomas Histotype Can Also be a High-Risk Factor for Stage II Colorectal Cancer Patients.
    Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai S
    Cell Physiol Biochem; 2018; 47(2):630-640. PubMed ID: 29794464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conclusions from a study of venous invasion in stage IV colorectal adenocarcinoma.
    Sternberg A; Amar M; Alfici R; Groisman G
    J Clin Pathol; 2002 Jan; 55(1):17-21. PubMed ID: 11825918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of venous invasion on the efficacy of adjuvant chemotherapy in elderly patients with stage III colorectal cancer.
    Hoshino N; Kawada K; Hida K; Goto S; Uozumi R; Hasegawa S; Sugihara K; Sakai Y
    Med Oncol; 2017 Aug; 34(8):138. PubMed ID: 28699092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy.
    Min BH; Bae JM; Lee EJ; Yu HS; Kim YH; Chang DK; Kim HC; Park CK; Lee SH; Kim KM; Kang GH
    BMC Cancer; 2011 Aug; 11():344. PubMed ID: 21827707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extratumoral vascular invasion is a significant prognostic indicator and a predicting factor of distant metastasis in non-small cell lung cancer.
    Shimada Y; Ishii G; Hishida T; Yoshida J; Nishimura M; Nagai K
    J Thorac Oncol; 2010 Jul; 5(7):970-5. PubMed ID: 20512073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apical Lymph Nodes in the Distant Metastases and Prognosis of Patients with Stage III Colorectal Cancer with Adequate Lymph Node Retrieval Following FOLFOX Adjuvant Chemotherapy.
    Tsai HL; Chen YT; Yeh YS; Huang CW; Ma CJ; Wang JY
    Pathol Oncol Res; 2019 Jul; 25(3):905-913. PubMed ID: 29299827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of intravascular stromal cells with prognosis in high-grade neuroendocrine carcinoma of the lung.
    Sekihara K; Hishida T; Ikemura S; Saruwatari K; Morise M; Kuwata T; Fujii S; Kojima M; Ochiai A; Funai K; Aokage K; Yoshida J; Tsuboi M; Ishii G
    J Cancer Res Clin Oncol; 2016 May; 142(5):905-12. PubMed ID: 26696594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer.
    Nishibeppu K; Komatsu S; Ichikawa D; Imamura T; Kosuga T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
    BMC Cancer; 2018 Jan; 18(1):108. PubMed ID: 29382310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic prognostic markers in stage IIA colorectal cancer: a comparative study.
    Barresi V; Reggiani Bonetti L; Ieni A; Branca G; Tuccari G
    Scand J Gastroenterol; 2016 Mar; 51(3):314-20. PubMed ID: 26554618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.